Literature DB >> 843119

Dermatomyositis complicating penicillamine treatment.

L Fernandes, D R Swinson, E B Hamilton.   

Abstract

A case of dermatomyositis developing during the course of treatment with D-penicillamine in a patient with rheumatoid arthritis is described. Complete remission occurred on withdrawal of the drug. Possible alternative diagnoses are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 843119      PMCID: PMC1006640          DOI: 10.1136/ard.36.1.94

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  [100 cases of common rheumatoid polyarthritis, treated with D-penicillamin].

Authors:  J P Camus; J Crouzet; P Guillien; C Benichou; J A Lievre
Journal:  Ann Med Interne (Paris)       Date:  1974-01

2.  [Penicillamine-induced polymyositis (author's transl)].

Authors:  U Bettendorf; R Neuhaus
Journal:  Dtsch Med Wochenschr       Date:  1974-12-06       Impact factor: 0.628

3.  Polymyositis and penicillamine.

Authors:  P L Schraeder; H A Peters; D S Dahl
Journal:  Arch Neurol       Date:  1972-11

4.  Significance of anti-D.N.A. antibodies in systemic lupus erythematosus.

Authors:  G R Hughes
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

5.  Hazards of penicillamine therapy in the treatment of rheumatoid arthritis.

Authors:  A T Day; J R Golding
Journal:  Postgrad Med J       Date:  1974-08       Impact factor: 2.401

6.  Monoclonal gammopathy penicillamine-induced polymyositis and systemic sclerosis.

Authors:  M Nishikai; Y Funatsu; M Homma
Journal:  Arch Dermatol       Date:  1974-08

7.  Toxic reactions to penicillamine in patients with Wilson's disease.

Authors:  J M Walshe
Journal:  Postgrad Med J       Date:  1968-10       Impact factor: 2.401

8.  Polymyositis in rheumatoid arthritis.

Authors:  D A Pitkeathly; E N Coomes
Journal:  Ann Rheum Dis       Date:  1966-03       Impact factor: 19.103

9.  Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.

Authors:  R C Bucknall; J Dixon A St; E N Glick; J Woodland; D W Zutshi
Journal:  Br Med J       Date:  1975-03-15

10.  Azathioprine hypersensitivity mimicking an acute exacerbation of dermatomyositis.

Authors:  D L Goldenberg; R A Stor
Journal:  J Rheumatol       Date:  1975-09       Impact factor: 4.666

View more
  9 in total

1.  Gottron's papules-like eruption developing under hydroxyurea therapy.

Authors:  Gleb Slobodin; Michael Lurie; Mariana Munichor; Julia Kovalev; Itzhak Rosner
Journal:  Rheumatol Int       Date:  2006-04-01       Impact factor: 2.631

2.  D-penicillamine-induced myositis in rheumatoid arthritis.

Authors:  R Chappel; J Willems
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

3.  Dermatomyositis exacerbated by abdominal Marlex mesh implantation: adjuvant effect?

Authors:  G Bernard-Medina; S Gutierrez-Urena; J Orozco-Alcala
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

4.  Dermatomyositis: observations on the use of immunosuppressive therapy and review of literature. Cairo--Glasgow study group.

Authors:  A El-Ghobarey; G Balint; K de Ceulaer; W C Dick; W W Buchanan; T Hadidi; T A Hassan
Journal:  Postgrad Med J       Date:  1978-08       Impact factor: 2.401

Review 5.  Penicillamine in rheumatoid arthritis. A problem of toxicity.

Authors:  H G Taylor; A Samanta
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

6.  Polymyositis complicating D-penicillamine treatment.

Authors:  A O Aydintug; R Cervera; D D'Cruz; G Ramírez; R A Asherson; M A Khamashta; G R Hughes
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

7.  Drug trials in rheumatoid arthritis.

Authors:  H Berry
Journal:  J R Soc Med       Date:  1980-12       Impact factor: 18.000

Review 8.  Environmental triggers of dermatomyositis: a narrative review.

Authors:  Christina E Bax; Spandana Maddukuri; Adarsh Ravishankar; Lisa Pappas-Taffer; Victoria P Werth
Journal:  Ann Transl Med       Date:  2021-03

9.  A case of polymyositis in a patient with primary biliary cirrhosis treated with D-penicillamine.

Authors:  J H Ahn; T H Kim; K R Peck; Y W Song
Journal:  Korean J Intern Med       Date:  1993-01       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.